Clinical Trial Update: A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing gemcitabine plus vinorelbine as first-line chemotherapy for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED